Zynex inc.

Get a real-time Zynex, Inc. (ZYXI) stock price quote with breaking news, financials, statistics, charts and more.WebOct 26, 2023 · Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient ... Zynex Inc is a medical technology company based in Englewood, Colorado. Founded in 1996, it is the leading provider of electrotherapy devices for pain management, stroke rehabilitation, and neurological assessment. Its products include electrotherapy, exercise systems, and stroke rehabilitation equipment, and its services include home health ...Zynex Inc (US:ZYXI) has 293 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These ...Zynex Inc's reported EPS for the quarter was 10 cents . The mean earnings estimate of analysts had fallen by about 25.3% in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. Zynex Inc shares had fallen by 11.3% this quarter and lost 49.0% so far this year.

Item 1.01. Entry Into or Amendment of a Material Definitive Agreement. On May 4, 2023, Zynex, Inc. priced a private offering of $52,500,000 in aggregate principal amount of its 5.00% Convertible...

Zynex, Inc. 9.32-0.05-0.51%: TRENDING. 1. Why it took 17 days for rescuers in India to get to 41 workers trapped in a mountain tunnel. 2. Amazon's AWS appeals to corporate customers with new ...

Mar 6, 2023 · ENGLEWOOD, Colo., March 6, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will postpone the release of its fourth quarter and full year financial results and conference call initially ... Jul 27, 2023 · Q2 2023 Revenue increased 22% to $45.0 Million; EPS $0.09. ENGLEWOOD, Colo., July 27, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has reported its financial and operational results for the second quarter ended June ... Zynex Inc (US:ZYXI) has 293 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These ...Hayward Pool Products Inc. is a leading manufacturer and distributor of swimming pool equipment and supplies. With over 80 years of experience, the company has been at the forefront of innovation in the swimming pool industry.

Zynex, Inc. founded in 1996, engineers, manufactures and markets neuro-diagnostics, stroke rehabilitation, pain management and cardiac monitoring devices within three subsidiaries. Zynex Medical ...

The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Our non-invasive medical technology improves the quality of life of patients with functional disability or intractable pain. Our TENS/IFC/NMES NexWave device has revolutionized the management of debilitating pain and is a safe alternative for pain management. Business Profile for Zynex Medical, Inc. Medical Equipment. At-a-glance. Contact Information. 9655 Maroon Cir. Englewood, CO 80112-5914. Visit Website (800) 495-6670. Want a quote from this business?Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. It also develops a new blood ...Zynex, Inc. raised $52.5 million via five percent convertible notes due in 2026 in May of this year. Verdict: Zynex made 44 cents a share of profit in FY2022 on just over $158 million in sales.Zynerba is an orphan-focused, neuropsychiatric, biopharmaceutical company taking a different and exciting transdermal approach to cannabinoids. Zynerba Pharmaceuticals has been acquired by Harmony Biosciences, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases ...Aug 9, 2023 · Zynex. 09 Aug, 2023, 09:15 ET. ENGLEWOOD, Colo., Aug. 9, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI ), an innovative medical technology company specializing in the manufacture and sale of non ...

Zynex, Inc. Common Stock (ZYXI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Zynex has 5 employees at their 1 location and $158.17 m in annual revenue in FY 2022. See insights on Zynex including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.Orbit Irrigation Products, Inc. commonly referred to as simply Orbit, produces irrigation products for residential and commercial home and garden use. Occasionally, you may need to reference one of Orbit’s product manuals for the proper use...На 02.12.2023 стоимость одной акции компании Zynex Inc составляет 9.04 долларов. Сделка по покупке актива производится на Санкт-Петербургской бирже. Доступна ...As of November 09, 2023, Zynex Inc. had a $306.8 million market capitalization, putting it in the 51st percentile of companies in the Advanced Medical Equipment & Technology industry. Currently, Zynex Inc.’s price-earnings ratio is 20.7. Zynex Inc.’s trailing 12-month revenue is $185.8 million with a 8.6% profit margin.Oct 22, 2019 · Zynex shares are up ~100x since late 2016 as retail investors buy into a story of rapid revenue and earnings growth. However, we believe Zynex is dependent on an abusive pricing strategy ...

Zynex, Inc. beats earnings expectations. Reported EPS is $0.1, expectations were $0.09. Operator: Good day ladies and gentlemen, and welcome to the Zynex Third Quarter 2023 Earnings Conference Call.

Zynex, Inc, together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with ...Zynex Inc. , which belongs to the Zacks Medical - Products industry, posted revenues of $42.17 million for the quarter ended March 2023, surpassing the Zacks Consensus Estimate by 6.30%. This ...About Zynex, Inc. Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com.Nov 15, 2023 · Zynex Inc. Stock Price History. Zynex Inc.’s price is currently down 0.68% so far this month. During the month of November, Zynex Inc.’s stock price has reached a high of $9.54 and a low of $8.68. Over the last year, Zynex Inc. has hit prices as high as $17.25 and as low as $6.88. Year to date, Zynex Inc.’s stock is down 2.69%. Zynex Inc. Stock Price History. Zynex Inc.’s price is currently down 0.68% so far this month. During the month of November, Zynex Inc.’s stock price has reached a high of $9.54 and a low of $8.68. Over the last year, Zynex Inc. has hit prices as high as $17.25 and as low as $6.88. Year to date, Zynex Inc.’s stock is down 2.69%.Zynex, Inc. develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. The Company's devices are intended for pain management and provide rehabilitation and through the utilization of …Zynex MedicalOn March 6, 2023, Zynex announced that the Company was postponing release of its fourth quarter and full year financial results and conference call initially scheduled for March 6, 2023 to allow ...

ENGLEWOOD, Colo., March 13, 2023 / PRNewswire / -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended December 31, 2022.

Zynex, Inc. (NASDAQ:NASDAQ:ZYXI) Q1 2023 Earnings Conference Call April 27, 2023 4:15 PM ETCompany ParticipantsLouisa Smith - Investor RelationsThomas...

ENGLEWOOD, Colo., Oct. 12, 2023 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on…Zynex, Inc. beats earnings expectations. Reported EPS is $0.09, expectations were $0.05. Quinn: Thomas Sandgaard – Chairman, President and Chief Executive Officer Anna Lucsok – Chief Operating ...A high-level overview of Zynex, Inc. (ZYXI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.WebZynex, Inc. develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. The Company's devices are intended for pain management and provide rehabilitation and through the utilization of …On March 6, 2023, Zynex announced that the Company was postponing release of its fourth quarter and full year financial results and conference call initially scheduled for March 6, 2023 to allow ...Zynex Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View ZYXI financial statements in full.The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.Contact: Zynex, Inc. (800) 495-6670. Investor Relations Contact: Gilmartin Group 650 Fifth Ave., Suite 2720 New York, NY 10019 [email protected] SOURCE Zynex.About Zynex, Inc. Zynex, founded in 1996, develops, manufacturers, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com. Contact: Zynex, Inc. (800) 495-6670Mar 13, 2023 · ENGLEWOOD, Colo., March 13, 2023 / PRNewswire / -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended December 31, 2022. Zynex's presentation will be held in person and webcast live on September 26 th at 1:35 PM ET at the InterContinental Barclay Hotel in New York, NY.You can listen to the webcast at Zynex Investor Presentation Webcast. Thomas Sandgaard, Founder and CEO, and Dan Moorhead, CFO, will be available for one-on-one meetings on September …About Zynex, Inc. Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation as well as developing noninvasive patient ...

Feb 24, 2022 · ENGLEWOOD, Colo., Feb. 24, 2022 / PRNewswire / -- Zynex, Inc. (Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended December 31, 2021. View all. Exercise Hot and Cold Therapy Evaluation Splints and Supports Modalities Treatment Furniture. Flat Rate Ground Shipping. $8.95 shipping on most products. Need Help? Contact our team at (800) 845-1771, M-F, 8am-4pm MT, or at [email protected], Inc. (NASDAQ:NASDAQ:ZYXI) Q1 2023 Earnings Conference Call April 27, 2023 4:15 PM ETCompany ParticipantsLouisa Smith - Investor RelationsThomas...Instagram:https://instagram. calculating portfolio betaforex brokers ukotcmkts rideqcsysb Nov 15, 2023 · ENGLEWOOD, Colo., Nov. 15, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked within Forbes' list of America's Most Successful Small-Cap Companies for 2024. mandt bank 203k loancost of sugar ENGLEWOOD, Colo., July 12, 2023 / PRNewswire / -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced preliminary results for second quarter 2023 and reiterated full-year guidance. best low cost financial advisors Zynex, Inc.(Nasdaq: ZYXI) an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported financial results for the fourth quarter and full year ended December 31, 2022.The good news is that Zynex is growing revenues, and EBIT margins improved by 11.7 percentage points to 18%, over the last year. Both of which are great metrics to check off for potential growth ...Zynex, Inc. is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis and cardiac monitoring. Thomas Sandgaard founded Zynex Medical in 1996. The company is based in unincorporated Douglas County, Colorado.